Private Advisor Group, LLC Sangamo Therapeutics, Inc Transaction History

Private Advisor Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$3.28 - $6.21 $2,837 - $5,371	865 Added 7.35%	12,631 $52,000
Q4 2021 Feb 10, 2022	SELL	$7.29 - $10.97 $133,290 - $200,575	-18,284 Reduced 60.85%	11,766 $89,000
Q3 2021 Oct 14, 2021	BUY	$9.01 - $12.01 $101,380 - $135,136	11,252 Added 59.86%	30,050 $271,000
Q2 2021 Aug 12, 2021	SELL	$10.17 - $12.64 $1,250 - $1,554	-123 Reduced 0.65%	18,798 $225,000
Q1 2021 Apr 22, 2021	SELL	$10.88 - $17.05 $34,065 - $53,383	-3,131 Reduced 14.2%	18,921 $237,000
Q4 2020 Apr 01, 2021	BUY	$9.23 - $18.18 $203,539 - $400,905	22,052 New	22,052 $344,000
Q3 2020 Nov 02, 2020	SELL	$9.38 - $12.48 $58,156 - $77,376	-6,200 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$6.21 - $11.83 $38,502 - $73,346	6,200 New	6,200 $56,000
Q1 2019 May 13, 2019	SELL	$7.72 - $12.81 $156,716 - $260,043	-20,300 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$9.51 - $16.6 $55,557 - $96,977	5,842 Added 40.41%	20,300 $233,000
Q3 2018 Nov 01, 2018	BUY	$13.05 - $19.05 $188,676 - $275,424	14,458 New	14,458 $245,000

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $135M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.